Observatoire Brestois Des Néoplasies Myéloprolifératives

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study. Myeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis. This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis

• Signature of the non-opposition consent form

Locations
Other Locations
France
CHRU de Brest
RECRUITING
Brest
Contact Information
Primary
Jean-Christophe Ianotto
jean-christophe.Ianotto@chu-brest.fr
Time Frame
Start Date: 2015-09-01
Estimated Completion Date: 2025-09-30
Participants
Target number of participants: 1000
Sponsors
Leads: University Hospital, Brest

This content was sourced from clinicaltrials.gov